Log In
BCIQ
Print this Print this
 

Plendil, felodipine

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionCalcium channel blocker
Molecular Target Calcium channel
Mechanism of ActionCalcium channel blocker
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHypertension
Indication DetailsTreat hypertension
Regulatory Designation
PartnerChina Medical System Holdings Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$310.0M

$310.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

02/29/2016

$310.0M

$310.0M

0

Get a free BioCentury trial today